-
Amgen Chief Executive Kevin Sharer acknowledges the company's significant challenges but says he can address all of them.
FORBES: Amgen's Enemies
-
What made Amgen Chief Executive Kevin Sharer , a former nuclear submarine officer and telecommunications executive, so interested in Enbrel?
FORBES: Amgen, Immunex: The Arthritis Merger
-
Amgen (AMGN) said late yesterday that chairman and chief executive officer Kevin Sharer will retire from the company at the end of 2012.
FORBES: People Moves: Amgen, New York Times
-
"We think at this point in the year we ought to be mindful of those reimbursement concerns, " Chief Executive Kevin Sharer told analysts in New York.
FORBES: Amgen: To Be Big Pharma or Not Big Pharma?
-
The next two years are crucial for Kevin Sharer.
FORBES: Companies, People, Ideas
-
Amgen Chief Executive Kevin Sharer has hopes that a new drug, denosumab, could become a "double blockbuster, " both as a twice-a-year treatment for osteoporosis and as a remedy for cancers of the bone.
FORBES: Amgen's Next Opponents